NorthStar Medical Radioisotopes, LLC, a global leader in developing, producing, and commercializing radiopharmaceuticals for therapeutic and imaging applications, announced that Kathy Spencer-Pike has been appointed Chief Commercial Officer, effective December 1, 2025. In her new role, Spencer-Pike will oversee the company’s commercial strategy, including sales, marketing, business development, customer engagement, and market expansion initiatives. She will work closely with cross-functional teams to align commercial objectives with NorthStar’s broader corporate goals, supporting sustainable growth and enhancing the company’s market leadership.
Health Technology Insights: KindlyMD Strengthens Leadership Team with Senior Finance Talent
Frank Scholz, President and CEO of NorthStar Medical Radioisotopes, said that Kathy brings extensive experience in scaling commercial organizations and driving revenue growth. He highlighted that her strategic insight, deep knowledge of the healthcare sector, and understanding of market dynamics will be vital as NorthStar continues to strengthen its competitive position and deliver value to customers.
Spencer-Pike has more than 25 years of experience leading commercial teams, launching products, and accelerating revenue in complex healthcare and life sciences markets. She has successfully developed innovative strategies that expand market presence, differentiate organizations, and create long-term value. Her career spans leadership roles in both Fortune 50 companies and high-growth startups, where she has consistently driven performance and growth.
Health Technology Insights: Bruker Adds Jack Phillips to Board of Directors in 2026
Commenting on her appointment, Spencer-Pike said she is excited to join NorthStar at a time when demand for reliable isotope supply and comprehensive radiopharmaceutical solutions is at an all-time high. She emphasized that NorthStar is well-positioned to capitalize on this momentum, scale rapidly, and drive industry progress. She added that she looks forward to building strong customer relationships and leading commercial growth that benefits both the company and its clients while enhancing patient care.
Most recently, Spencer-Pike served as Chief Commercial Officer at Nucleus RadioPharma, where she developed commercial strategy, scaled marketing and business development, and aligned cross-functional operations to support clinical and commercial readiness. Prior to that, she held senior commercial roles at McKesson and CoverMyMeds, managing large integrated teams, driving double-digit growth, and achieving industry-leading client retention. She also held commercial leadership positions at Novo Nordisk, Sanofi, and Pfizer.
Spencer-Pike earned a Bachelor of Science from Eastern Kentucky University in Richmond, Kentucky, and a Master of Arts in Mental Health Counseling from Webster University in Orlando, Florida.
Health Technology Insights: IBMI SNQ and ICHOM Partner to Advance Patient Care in Asia
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
